Oxidized phospholipids inhibit cyclooxygenase-2 in human macrophages via nuclear factor-κB/IκB- and ERK2-dependent mechanisms

Cardiovascular Research

Volumn 55, Issue 2, 2002, Pages 406-415

  Eligini, Sonia ^a   Brambilla, Marta ^a   Banfi, Cristina ^a   Camera, Marina ^a   Sironi, Luigi ^a   Barbieri, Silvia Stella ^a   Auwerx, Johan ^b   Tremoli, Elena ^a   Colli, Susanna ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Atherosclerosis; Infection inflammation; Macrophages; Prostaglandins; Signal transduction

Indexed keywords

CYCLOOXYGENASE 2; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; NITRIC OXIDE SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHOSPHOLIPID;

ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DOSE RESPONSE; DOWN REGULATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INCUBATION TIME; MACROPHAGE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

CELL CULTURE TECHNIQUES; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; HUMANS; I-KAPPA B PROTEINS; ISOENZYMES; LIPOPOLYSACCHARIDES; LIPOPROTEINS, LDL; MACROPHAGES; MEMBRANE PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RNA, MESSENGER;

EID: 0036070318     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(02)00437-6     Document Type: Article

References (45)

1. Atherosclerosis: An inflammatory disease
2. Demonstration of an inducible cyclooxygenase in human endothelial cells using antibodies raised against the carboxyl-terminal region of the cyclooxygenase-2
3. Redundancy in the signaling pathways and promoter elements regulating cyclooxygenase-2 gene expression in endotoxin-treated macrophages/monocytic cells
4. Expression of mitogen-inducible cyclooxygenase induced by lipopolysaccharide: Mediation through both mitogen-activated protein kinase and NF-κB signaling pathways in macrophages
5. Cyclooxygenase-2 expression in macrophages: Modulation by protein kinase C-α
6. Transcriptional role of the nuclear factor κB site in the induction by lipopolysaccharide and suppression by dexamethasone of cyclooxygenase-2 in U937 cells
7. Function and activation of NF-κB in the immune system
8. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
9. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
10. Activation of human aortic smooth-muscle cells is inhibited by PPARα but not PPARγ activators
11. Oxidized low density lipoprotein suppresses expression of inducible cyclooxygenase in human macrophages
12. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo
13. Role of group II secretory phospholipase A2 in atherosclerosis 2. Potential involvement of biologically active oxidized phospholipids
14. The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide
15. An evaluation of the Coomassie Brilliant Blue G-250 dye-binding method for quantitative protein determination
16. Very low density lipoprotein-mediated signal transduction and plasminogen activator inhibitor type1in cultured HepG2 cells
17. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues
18. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
19. Vastatins inhibit tissue factor in cultured human macrophages: A novel mechanism of protection against atherothrombosis
20. Lipopolysaccharide modulates cyclooxygenase-2 transcriptionally and posttranscriptionally in human macrophages independently from endogenous IL-1β and TNF-α
21. The nuclear receptors peroxisome proliferator-activated receptor α and apolipoprotein A-I expression by fibrates
22. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein
23. Oxidized low density lipoprotein suppresses activation of NF-κB in macrophages via a pertussis toxine-sensitive signaling mechanism
24. Oxidized LDL modulates activation of NF-κB in mononuclear phagocytes by altering the degradation of Iκ-Bs
25. Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-κB to DNA and the subsequent expression of tumor necrosis factor-α and interleukin-1β in macrophages
26. Oxidized phospholipids activate PPARα in a phospholipase A2-dependent manner
27. Role for peroxisome proliferator activated receptor α in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells
28. Activation of proliferator-activated receptors α and γ induces apoptosis of human monocyte-derived macrophages
29. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ
30. 2 is a ligand for the adipocyte determination factor PPARγ
31. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation
32. Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptorγ
33. A synthetic antagonist for the peroxisome proliferator-activated receptor γ inhibits adipocyte differentiation
34. Oxidized lipids in atherogenesis: Formation, destruction and action
35. Oxidized phospholipids and isoprostanes in atherosclerosis
36. Increase in fragmented phosphatidylcholine in blood plasma by oxidative stress
37. Activation of transcription factor NF-kB and p38 mitogen-activated protein kinase is mediated by distinct and separate stress effector pathways
38. Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction
39. The lipoxygenase product 13-hydroxyoctadecadienoic acid (13-HODE) is a selective inhibitor of classical PKC isoenzymes
40. 2 inhibits multiple steps in the NF-κB signaling pathway
41. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
42. 2 in activated murine macrophages
43. Inhibition of lipopolysaccharide-induced interleukin 1β mRNA expression in mouse macrophages by oxidized low density lipoprotein
44. Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-γ and nuclear factor-κB